SelectQuote Investors Urged to Act Before Deadline Approaches
Bragar Eagel & Squire, P.C., a notable firm specializing in stockholder rights, is actively reaching out to investors of SelectQuote, Inc. (NYSE: SLQT) to notify them about the ongoing class-action lawsuit. This initiative aims to protect the legal rights of all who purchased securities in SelectQuote from September 9, 2020, to May 1, 2025. If you fall within this timeframe and have experienced financial losses, it is vital to connect with the firm.
Understanding the Current Situation
As of late September 2025, a significant lawsuit has been filed against SelectQuote in the United States District Court for the Southern District of New York. The allegations point toward claims of misconduct that could have serious implications for the company and its investors. This legal action is urging all affected investors who acquired SelectQuote's securities during the specified class period to make their voices heard.
What Are the Key Allegations?
The core of the lawsuit revolves around claims that SelectQuote has engaged in misleading practices regarding their business operations. Specifically, it has been alleged that from approximately 2016 through 2021, the company received substantial illegal kickbacks from health insurance entities. These kickbacks were apparently given in exchange for directing Medicare beneficiaries toward plans that were profitable for SelectQuote, disregarding the beneficiaries’ best interests.
The Impact on Investors
Following the revelations of these allegations, there was a noteworthy impact on SelectQuote's stock price, which plummeted by 19.2% on the day the news broke, closing at $2.56 per share. This decline reflects the market's reaction to the serious nature of the allegations and emphasizes the importance for investors to reconsider their positions in the company.
Taking Action: What Should Investors Do?
Time is of the essence for investors who believe they may have been misled or suffered losses due to these circumstances. The deadline to apply as a lead plaintiff in this lawsuit is approaching quickly, with October 10, 2025 marking the cut-off. Investors who suffered losses during the specified class period should not hesitate to reach out to Bragar Eagel & Squire to discuss their potential legal options.
How to Get in Touch
If you're an investor looking to discuss your situation, you can contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire. They can be reached directly at (212) 355-4648. There are no costs or obligations involved in this process, and determining your options is crucial in navigating these challenging waters.
Why Choose Bragar Eagel & Squire?
Bragar Eagel & Squire, P.C. has built a reputation as a trusted law firm representing individual and institutional investors in complex litigation across state and federal courts. With a focus on protecting the rights of their clients, they are well-equipped to handle matters concerning securities and business litigation, making them a solid choice for investors impacted by this situation.
Frequently Asked Questions
What should SelectQuote investors do regarding the lawsuit?
Investors are encouraged to contact Bragar Eagel & Squire to explore their legal options and discuss any potential claims.
What is the deadline for investors to take action?
The deadline to apply as a lead plaintiff in the class-action lawsuit is October 10, 2025.
Who can join the class-action lawsuit?
All individuals and entities that purchased or acquired securities in SelectQuote between September 9, 2020, and May 1, 2025, are eligible to join.
What are the allegations against SelectQuote?
Allegations include receiving illegal kickbacks from health insurance companies and misleading claims regarding the services offered.
How can I contact the law firm?
You can reach Bragar Eagel & Squire at (212) 355-4648 or via email at investigations@bespc.com for inquiries.
